Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma, Non-Hodgkin 4Lymphoma 4Prostatic Neoplasms 3Myelodysplastic Syndromes 3Leukemia 3Hematologic Neoplasms 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Multiple Myeloma 2Lymphoma, B-Cell 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Colonic Neoplasms 2Cardiotoxicity 2Carcinoma in Situ 2Burkitt Lymphoma 2Breast Neoplasms 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Sleep Initiation and Maintenance Disorders 1Recurrence 1Philadelphia Chromosome 1Peritoneal Neoplasms 1Papillomavirus Infections 1

Interventions

Electrocardiography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Brugada Syndrome × Electrocardiography × Clear all
NCT07364656 2026-01-23

Analysis of the Presence and Cardiac Functional Effects of Anti-NaV1.5 Autoantibodies in Patients With Metastatic Tumors

IRCCS Policlinico S. Donato

Phase NA Not yet recruiting
196 enrolled
Gastrointestinal

Colonic Neoplasms, Brugada Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡